(Q40681607)

22 September 2017

title

Regulation of Bcl-2 during androgen-unresponsive progression of prostate cancer (English)

1 reference

22 September 2017

Rothermund CA

1

1 reference

22 September 2017

Kondrikov D

series ordinal

2

1 reference

22 September 2017

Lin MF

series ordinal

3

1 reference

22 September 2017

Vishwanatha JK

series ordinal

4

1 reference

22 September 2017

publication date

1 January 2002

1 reference

Prostate Cancer and Prostatic Diseases

22 September 2017

published in

1 reference

22 September 2017

volume

5

1 reference

22 September 2017

issue

3

1 reference

22 September 2017

page(s)

236-245

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.pcan.4500582

22 September 2017

exact match

0 references

cites work

Target to apoptosis: a hopeful weapon for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500582

The relationship between BcI2, Bax and p53: consequences for cell cycle progression and cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500582

p53 oncogene mutations in three human prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500582

Phenotypic and genotypic characterization of commonly used human prostatic cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500582

The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500582

Unusual specificity of the androgen receptor in the human prostate tumor cell line LNCaP: high affinity for progestagenic and estrogenic steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500582

Activation of Rb and decline in androgen receptor protein precede retinoic acid-induced apoptosis in androgen-dependent LNCaP cells and their androgen-independent derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500582

Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: molecular characterization of the involved signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500582

Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500582

BCL-2 family members and the mitochondria in apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500582

The Bcl-2 protein family: arbiters of cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500582

21 January 2018

Cancer statistics, 1993

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500582

7 January 2021

Overview of phase III trials on combined androgen treatment in patients with metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500582

7 January 2021

Activation of programmed (apoptotic) cell death for the treatment of prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500582

7 January 2021

Resistance to apoptosis and up regulation of Bcl-2 in benign prostatic hyperplasia after androgen deprivation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500582

7 January 2021

Expression of human prostatic acid phosphatase correlates with androgen-stimulated cell proliferation in prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500582

7 January 2021

Identifiers

DOI

10.1038/SJ.PCAN.4500582

1 reference

Dimensions Publication ID

22 September 2017

1040133574

0 references

1 reference